The bipartisan duo attempting to modify the FDA’s deeming regulations in the US Congress reacted with cautious optimism to commissioner Scott Gottlieb’s sweeping new policy plan, which many see as a nod for safer alternatives to traditional tobacco products. ...
Sign up to access to our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
